{
  "cik": "0001610820",
  "name": "BriaCell Therapeutics Corp.",
  "entityType": "operating",
  "sic": "2834",
  "sicDescription": "Pharmaceutical Preparations",
  "stateOfIncorporation": "A1",
  "stateOfIncorporationDescription": "British Columbia, Canada",
  "fiscalYearEnd": "0731",
  "tickers": [
    "BCTX",
    "BCTXW",
    "BCTXZ"
  ],
  "exchanges": [
    "Nasdaq",
    "Nasdaq",
    "Nasdaq"
  ],
  "ein": "000000000",
  "description": "",
  "website": "",
  "investorWebsite": "",
  "category": "<br>Emerging growth company",
  "phone": "(604) 921-1810",
  "flags": "",
  "formerNames": [
    {
      "name": "Ansell Capital Corp.",
      "from": "2014-06-20T04:00:00.000Z",
      "to": "2014-06-20T04:00:00.000Z"
    }
  ],
  "filings_count": 276,
  "download_timestamp": "2025-08-02 07:18:37 UTC"
}